TG Therapeutics (NASDAQ:TGTX) Delivers Shareholders Solid 15% CAGR Over 5 Years, Surging 6.6% in the Last Week Alone

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on a lighter note, a good company can see its share price rise well

Simply Wall StJun 22 08:01 ET

Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)

Yahoo FinanceJun 21 03:09 ET

TG Therapeutics(TGTX.US) Director Sells US$432.89K in Common Stock

$TG Therapeutics(TGTX.US)$ Director Lonial Sagar sold 25,933 shares of common stock on Jun 17, 20, 2024 at an average price of $16.69 for a total value of $432.89K.Source: Announcement What is stateme

moomoo NewsJun 20 18:51 ET

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

PALM BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it

GlobeNewswireJun 11 08:45 ET

Express News | Calstrs: Decided to Vote Against Laurence Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, Sagar Loniel, Michael Weiss at TG Therapeutics' AGM

ReutersJun 10 11:38 ET

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PDF Version Fireside chat scheduled for Tuesday, June 11, 2024, at 1:20 PM ETNEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Wei

TG TherapeuticsJun 7 00:00 ET